台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

佳醫健康事業股份有限公司 新北市中和區中正路880號17樓 (22854522) - sodium chloride;;calcium chloride;;potassium chloride;;magnesium chloride;;acetic acid;;dextrose;;sodium chloride;;sodium bicarbonate ( eq to sodium hydrogen carbonate) - 透析用液劑 - calcium chloride (4012000300) gm; magnesium chloride (4012001500) gm; potassium chloride (4012001800) gm; sodium chloride (4012002100) gm; dextrose (4020000500) 73.7gm; acetic acid (9600000300) gm; sodium bicarbonate ( eq to sodium hydrogen carbonate) (4008000700) 65.95gm; sodium chloride (4012002100) gm - hemodialytics, concentrates - 配合洗腎機及人工腎臟用以清洗腎臟病病人之血中尿毒

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

台灣費森尤斯卡比股份有限公司 台北市大安區仁愛路三段30號5樓32號5樓 (12980985) - pemetrexed disodium heptahydrate - 凍晶注射劑 - pemetrexed disodium heptahydrate (1004002410) pemetrexed (as pemetrexed disodium) (pemetrexed disodium is formed in situ from pemetrexed diacid)mg - pemetrexed - 1.併用cisplatin是治療局部晚期或轉移性非小細胞肺癌（顯著鱗狀細胞組織型除外）之第一線化療用藥。2.pemetrexed單一藥物是局部晚期或轉移性非小細胞肺癌（顯著鱗狀細胞組織型除外）病人接受4個週期含鉑藥物的第一線化療後疾病並未惡化之維持療法。3.單一藥物是治療局部晚期或轉移性非小細胞肺癌（顯著鱗狀細胞組織型除外）之第二線治療用藥。4.與cisplatin併用於治療惡性肋膜間質細胞瘤。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

台灣費森尤斯卡比股份有限公司 台北市大安區仁愛路三段30號5樓32號5樓 (12980985) - pemetrexed disodium heptahydrate - 凍晶注射劑 - pemetrexed disodium heptahydrate (1004002410) pemetrexed (as pemetrexed disodium) (pemetrexed disodium is formed in situ from pemetrexed diacid)mg - pemetrexed - 1.併用cisplatin是治療局部晚期或轉移性非小細胞肺癌（顯著鱗狀細胞組織型除外）之第一線化療用藥。2.pemetrexed單一藥物是局部晚期或轉移性非小細胞肺癌（顯著鱗狀細胞組織型除外）病人接受4個週期含鉑藥物的第一線化療後疾病並未惡化之維持療法。3.單一藥物是治療局部晚期或轉移性非小細胞肺癌（顯著鱗狀細胞組織型除外）之第二線治療用藥。4.與cisplatin併用於治療惡性肋膜間質細胞瘤。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

台灣參天製藥股份有限公司 台北市中山區松江路126號9樓之1 (86383884) - tetrahydrozoline hcl;;neostigmine methylsulfate;;aminocaproic acid epsilon-;;glycyrrhizinate dipotassium (eq to dipotassium glycyrrhizinate);;zinc sulfate hydrate;;chlorpheniramine maleate;;cyanocobalamin (vit b12);;pyridoxine hydrochloride;;panthenol;;potassium l-aspartate ;;taurine (eq to 2-aminoethane sulfonic acid);;chondroitin sulfate sodium (eq to sodium chondroitin sulfate ) - 點眼液劑 - chlorpheniramine maleate (0400000810) (100ml~0.03g)mg; neostigmine methylsulfate (1204000920) (100ml~0.005g)mg; aminocaproic acid epsilon- (2012100201) (100ml~1.0g)mg; chondroitin sulfate sodium (eq to sodium chondroitin sulfate ) (2406000310) (100ml~0.5g)mg; potassium l-aspartate (4020100441) (100ml~0.5g)mg; tetrahydrozoline hcl (5232000310) (100ml~0.03g)mg; panthenol (8416000700) (100ml~0.05g)mg; pyridoxine hydrochloride (8810600330) (100ml~0.05g)mg; cyanocobalamin (vit b12) (8811200300) (100ml~0.02g)mg; taurine (eq to 2-aminoethane sulfonic acid) (9200000900) (100ml~0.5g)mg; glycyrrhizinate dipotassium (eq to dipotassium glycyrrhizinate) (9200004620) (100ml~0.1g)mg; zinc sulfate hydrate (9200010630) (100ml~0.05g)mg - other ophthalmologicals - 暫時緩解因輕微眼部刺激所引起之不適、或眼睛紅，眼睛癢、眼睛疲勞。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

台灣參天製藥股份有限公司 台北市中山區松江路126號9樓之1 (86383884) - tetrahydrozoline hcl;;neostigmine methylsulfate;;aminocaproic acid epsilon-;;chlorpheniramine maleate;;retinol palmitate;;tocopherol acetate alpha d-;;potassium l-aspartate ;;taurine (eq to 2-aminoethane sulfonic acid);;chondroitin sulfate sodium (eq to sodium chondroitin sulfate ) - 點眼液劑 - chlorpheniramine maleate (0400000810) mg; neostigmine methylsulfate (1204000920) mg; aminocaproic acid epsilon- (2012100201) mg; chondroitin sulfate sodium (eq to sodium chondroitin sulfate ) (2406000310) mg; potassium l-aspartate (4020100441) mg; tetrahydrozoline hcl (5232000310) mg; retinol palmitate (8428001920) lf(units); tocopherol acetate alpha d- (8820000211) mg; taurine (eq to 2-aminoethane sulfonic acid) (9200000900) mg - other ophthalmologicals - 暫時緩解因輕微眼部刺激所引起之不適、或眼睛紅，眼睛癢，眼睛疲勞。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

荷蘭商歐嘉隆有限公司台灣分公司 臺北市信義區松仁路97號4樓 (83698783) - mirtazapine (as coated mirtazapine containing 24% active ingredient) - 口溶錠 - mirtazapine (as coated mirtazapine containing 24% active ingredient) (2816901720) eq to mirtazapine 30mgmg - mirtazapine - 鬱症。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

金源貿易股份有限公司 台北巿漢中街１４７巷１２號 (15213918) - medical devices - 衛生材料 - 主成分 () ; medical devices (9400000099) - 捻挫、扭筋、脫臼之固定、外科之處理時用於：保護被覆屈曲部份　＊＊ＷＡＲＰＴＨＲＥＡＤＳ　ＡＲＥ　ＡＲＲＡＮＧＥＤ　ＡＳ　ＦＯＬＬＯＷＳ：ＯＮＥＢＵＭＥＬＯＮ　ＴＨＲＥＡＤ，ＴＷＯ　ＲＡＹＯＮ　ＴＨＲＥＡＤＳ，ＲＥＰＥＡＴＥＤ，ＥＮＤＩＮＧ　ＷＩＴＨ　ＢＵＭＥＬＯＮ　ＴＨＲＥＡＤ．　ＴＨＥ　ＢＵＭＥＬＯＮ　ＹＡＲＮ　　　　＊＊

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

人人化學製藥股份有限公司 桃園市中壢區南園二路３號 (30840213) - charcoal;;sodium bicarbonate ( eq to sodium hydrogen carbonate) - 錠劑 - sodium bicarbonate ( eq to sodium hydrogen carbonate) (4008000700) 250mg; charcoal (5604001500) (medical) 65mg - other drugs for acid related disorders - 緩解胃部不適或灼熱感、或經診斷為胃及十二指腸潰瘍、胃炎、食道炎所伴隨之胃酸過多。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

台灣柏朗股份有限公司 台北市松山區健康路152號9樓 (23525106) - poly(o-2- hydroxyethyl)starch (hes)(molar subs 0.42; average molecular weight 130000 da);;sodium chloride;;potassium chloride;;calcium chloride dihydrate;;magnesium chloride hexahydrate (eq to magnesium chloride 6h2o);;sodium acetate trihydrate (eq to sodium acetate 3h2o );;malic acid - 注射液劑 - sodium acetate trihydrate (eq to sodium acetate 3h2o ) (4008000670) mg; calcium chloride dihydrate (4012000350) mg; magnesium chloride hexahydrate (eq to magnesium chloride 6h2o) (4012001550) mg; potassium chloride (4012001800) mg; sodium chloride (4012002100) mg; poly(o-2- hydroxyethyl)starch (hes)(molar subs 0.42; average molecular weight 130000 da) (9600009069) mg; malic acid (9600017800) mg - blood substitutes and plasma protein fractions - 單獨使用晶質輸注液無法治療之急性出血導致之低血容積病人，本品無法取代紅血球及血漿中的凝血因子。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

台灣柏朗股份有限公司 台北市松山區健康路152號9樓 (23525106) - poly(o-2- hydroxyethyl)starch (hes)(molar subs 0.42; average molecular weight 130000 da);;sodium chloride;;potassium chloride;;calcium chloride dihydrate;;magnesium chloride hexahydrate (eq to magnesium chloride 6h2o);;sodium acetate trihydrate (eq to sodium acetate 3h2o );;malic acid - 注射液劑 - sodium acetate trihydrate (eq to sodium acetate 3h2o ) (4008000670) mg; calcium chloride dihydrate (4012000350) mg; magnesium chloride hexahydrate (eq to magnesium chloride 6h2o) (4012001550) mg; potassium chloride (4012001800) mg; sodium chloride (4012002100) mg; poly(o-2- hydroxyethyl)starch (hes)(molar subs 0.42; average molecular weight 130000 da) (9600009069) mg; malic acid (9600017800) mg - blood substitutes and plasma protein fractions - 單獨使用晶質輸注液無法治療之急性出血導致之低血容積病人，本品無法取代紅血球及血漿中的凝血因子。